153 related articles for article (PubMed ID: 9443984)
1. Genetics of pancreatic cancer. From genes to families.
Hruban RH; Petersen GM; Ha PK; Kern SE
Surg Oncol Clin N Am; 1998 Jan; 7(1):1-23. PubMed ID: 9443984
[TBL] [Abstract][Full Text] [Related]
2. [Genetics of pancreatic cancer: recent advances in molecular diagnosis].
Hayashi N; Egami H; Ogawa M
Nihon Geka Gakkai Zasshi; 2002 Jun; 103(6):476-81. PubMed ID: 12094699
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis of pancreatic cancer.
Inoue S; Tezel E; Nakao A
Hepatogastroenterology; 2001; 48(40):933-8. PubMed ID: 11490843
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of pancreatic cancer.
Hruban RH; Iacobuzio-Donahue C; Wilentz RE; Goggins M; Kern SE
Cancer J; 2001; 7(4):251-8. PubMed ID: 11561601
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in gene change of pancreatic cancer].
Wang YY; Cui QC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
[TBL] [Abstract][Full Text] [Related]
6. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
Talar-Wojnarowska R; Malecka-Panas E
Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of pancreatic cancer.
Maitra A; Kern SE; Hruban RH
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
[TBL] [Abstract][Full Text] [Related]
10. [Alterations of the p16 gene for the carcinogenesis in pancreas].
Wang C; Lu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Oct; 22(5):491-3. PubMed ID: 12903437
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of neoplasia in multiple endocrine neoplasia type 1-related and sporadic tumors of the pancreatic islet cells.
Bale AE
Endocrinol Metab Clin North Am; 1994 Mar; 23(1):109-15. PubMed ID: 7913019
[TBL] [Abstract][Full Text] [Related]
12. Molecular prognostic markers in pancreatic cancer.
Ghaneh P; Kawesha A; Evans JD; Neoptolemos JP
J Hepatobiliary Pancreat Surg; 2002; 9(1):1-11. PubMed ID: 12021893
[TBL] [Abstract][Full Text] [Related]
13. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
Dammann R; Schagdarsurengin U; Liu L; Otto N; Gimm O; Dralle H; Boehm BO; Pfeifer GP; Hoang-Vu C
Oncogene; 2003 Jun; 22(24):3806-12. PubMed ID: 12802288
[TBL] [Abstract][Full Text] [Related]
14. Familial pancreatic cancer: from genes to improved patient care.
Hruban RH; Klein AP; Eshleman JR; Axilbund JE; Goggins M
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):81-8. PubMed ID: 19072437
[TBL] [Abstract][Full Text] [Related]
15. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
16. Characterization of FAMPAC, a newly identified human pancreatic carcinoma cell line with a hereditary background.
Eisold S; Ryschich E; Linnebacher M; Giese T; Nauheimer D; Wild A; Bartsch DK; Büchler MW; Schmidt J
Cancer; 2004 May; 100(9):1978-86. PubMed ID: 15112280
[TBL] [Abstract][Full Text] [Related]
17. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
18. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
20. Identification of high-risk pancreatic cancer-prone families.
Brand RE; Lynch HT
Gastroenterol Clin North Am; 2004 Dec; 33(4):907-18. PubMed ID: 15528025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
